NEW ORLEANS, LA--(Marketwire - Mar 4, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) today announced that through its wholly owned subsidiary, MyMedicalRecords, Inc., it has reached an agreement to license MMR's extensive health IT patent portfolio, which includes seven U.S. patents -- Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240 -- to Olympia Medical Center. The License Agreement also includes rights to additional pending applications and continuation applications, all of which involve inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. Olympia is a Los Angeles-based hospital with 204 beds, staffed by more than 600 physicians representing over 40 specialties, and known for its continuous program enhancement and excellence in service. With the latest license, the Company goes into its first day at HIMSS with royalty-based license agreements with EHR vendors, surgery centers, PHR vendors, Interbit Data, wellness providers, Burkhart Dental, and hospitals in addition to reseller relationships with healthcare professionals, associations, retailers and others as a direct result of MMR's patented IP embedded in its MyMedicalRecords Personal Health Record and MMRPro document management and imaging services for healthcare professionals. The Company is exhibiting at the HIMSS 2013 Annual Conference and Exhibition, in booth #3363.
As a result of heightened awareness of the MyMedicalRecords patent portfolio, the Company will be meeting with hospital administrators, providers, retail pharmacies, patient monitoring and telemedicine service providers and laboratories, as well as other software and equipment vendors in the healthcare and wellness markets. Without a license to the MMR patent portfolio, hospitals and providers could find themselves infringing on MMR's IP, since in order to fully qualify for incentives under the HITECH Act, Meaningful Use core requirements to provide patients access to their personal health information through a Web-based portal must be met.
According to a study and valuation done on the Company's global patent portfolio, there are more than 5,500 hospitals, 150 PHR vendors and 750 EMR vendors as well as providers, payers and pharmacies that are potential licensees of the MMR Patent Portfolio. The detailed report is available at http://michaelbass.com/PDF/Patent_Valuation.pdf.
The Company has also said it will also meet with investment bankers and institutional investors interested in syndicating limited partnership interests in the Company's international health information technology patent portfolios which include twelve additional countries of commercial interest with patents issued pending and applied for in Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, South Korea, Israel, and European nations. As in the United States, the patents involve inventions pertaining to Personal Health Records, Patient Portals and other Electronic Medical Record systems.
Last week, MMR announced it will introduce an Integrated Wellness Mobile App at HIMSS. The App is a comprehensive, self-management system which allows users to take control of their own health and wellness, connect wirelessly with their MyMedicalRecords Personal Health Record, and share information with health providers and wellness coaches.
The MyMedicalRecords patent portfolio further includes claims directed to Web-based services that provide access to and collect health records from service providers, including, but not limited to, retail pharmacies and laboratory systems as well as hospitals, physicians and other healthcare professionals, using email, facsimile, file upload, HL7, encrypted PDF and voice. Certain claims in newly allowed applications also relate to collecting insurance information, appointment and medication reminders, drug interaction tools and other features that are already included in MMR's MyMedicalRecords.com PHR.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.
All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property enforcement actions, infringement claims or litigation, intellectual property licenses, and future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission, including disclosures about the Company's relationship with the Michael Bass Group since 2009. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.